Some good news on the weight-loss front: Customers can now go to Costco to get Ozempic and Wegovy, brand-name injectable prescription drugs manufactured by drug maker Novo Nordisk, which contain the same active ingredient: semaglutide.
The Danish pharmaceutical firm announced Friday that both are available at the big-box retailer’s pharmacies nationwide, for $499 for a month’s supply—the same price as sold in CVS, Walmart, and the company’s direct-to-consumer website. You’ll still need a prescription to buy the drugs.
Fast Company has reached out to both Costco and Novo Nordisk for comment.
Also—Costco is offering a 2% discount for both Costco executive members and Costco Citibank Visa card holders, according to CBS News.
Both drugs are similar, but the Food and Drug Administration (FDA) has approved them for two different reasons. Wegovy is approved for chronic weight management, while Ozempic is approved for treating type 2 diabetes, to reduce the risk of cardiovascular health issues including heart attack, stroke, and death. Ozempic is prescribed “off-label” for weight loss.
The main difference is that they have different side effects and dosages—and because Wegovy is administered at higher doses, a maximum of 2.4 mg a week, it leads to both greater weight loss and more gastrointestinal side effects. Ozempic is typically administered at 2 mg per week. Each are injected once a week.
Costco financials
Costco Wholesale Corporation (COST) stock was down less than one percent on Monday in afternoon trading.
The company reported fourth quarter earnings for the period ending August 31, 2025, with net sales for the quarter up 8%, to $84.4 billion from $78.2 billion last year. Net sales for the fiscal year increased 8.1%, to $269.9 billion from $249.6 billion last year.
Costco currently has a market capitalization of $402.6 billion.